Funding Details
- Date Award
- May 13, 2024
- Vertical
- Therapeutics
- Funding URL
- View Funding Page
Company Info
- Organizations Involved
- None
- Founders
- Christopher P. Marshall, Mark Yondola
- Company Description
- Calder is a nano-scale, molecular engineering company that is applying its platform technology to engineer and develop novel vaccines that allow billions of people to stay healthy. We’re developing safe, effective, durable, and tolerable vaccines that protect against RSV, all strains of seasonal and pandemic influenza, and other harmful, viral infections.
- Location
-
United States
- Coinvestors
- None
Links